Fabry Cardiomyopathy: Current Treatment and Future Options

Fabry disease is a multisystem X-linked lysosomal storage disorder caused by a mutation in the alpha-galactosidase A gene. Deficiency or reduced activity of alpha-galactosidase A (GLA) is leading to progressive intracellular accumulation of globotriaosylceramide (GL3) in various organs, including th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vardarli, Irfan, Weber, Manuel, Rischpler, Christoph, Führer, Dagmar, Herrmann, Ken, Weidemann, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305771/
https://www.ncbi.nlm.nih.gov/pubmed/34300196
http://dx.doi.org/10.3390/jcm10143026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305771/
https://www.ncbi.nlm.nih.gov/pubmed/34300196
http://dx.doi.org/10.3390/jcm10143026

Ejemplares similares